Ongoing monitoring and dose adjustment : Peptide therapy isnt one-size-fits-all
A meta-analysis has showed that reducing sodium intake in people with T1DM and T2DM improves blood pressure [345], and another RCT showed that in people with T2DM, limiting sodium intake to an average of 2,310 mg/day, along with the DASH diet, improved CVD risk factors, including blood pressure [346]
These moves do not yet define a mature category, but they do confirm that large and mid-scale operators see real commercial demand
Having clinicians and coaches who specialize in male weight loss means better-tailored protocols, including attention to testosterone preservation during rapid weight loss
With Mounjaro no longer in shortage, MedSpas that use FDA-approved drugs may see an increase in patient trust and satisfaction